Influence of HEMA on LPS- and LTA-stimulated IL-6 release from human dental pulp cells

Dent Mater. 2022 May;38(5):886-897. doi: 10.1016/j.dental.2022.03.008. Epub 2022 Mar 25.

Abstract

Objective: Dental pulp cells interact with immunogenic components such as LPS (lipopolysaccharide) or LTA (lipoteichoic acid) released from microorganisms in carious lesions. In the present investigation, the formation of the pro-inflammatory cytokines TNFα and IL-6 in LPS- or LTA-stimulated cells from the dental pulp interface and pulp fibroblasts was analyzed in the presence of the resin monomer 2-hydroxyethyl methacrylate (HEMA) under varying cellular redox conditions.

Method: Human pulp fibroblasts (HPC) or cells from the dental pulp interface expressing an odontoblast phenotype (hOD-1) were exposed to LTA, LPS or HEMA for 1 h or 24 h. Redox homeostasis was modified by the prooxidant BSO (L-buthionine sulfoximine) or the antioxidant NAC (N-acetyl cysteine). Formation of TNFα or IL-6 was analyzed by ELISA, and cell survival was determined by a crystal violet assay. Statistical analyses were performed using the Mann-Whitney-U-test.

Results: Secretion of TNFα was not detected in LPS- or LTA-stimulated HPC or hOD-1, and IL-6 was not found after a short exposure (1 h). After a 24 h exposure, LPS induced a 3-fold increase in IL-6 formation in HPC, while LTA stimulated IL-6 release about 20-fold. Likewise, LTA was more effective than LPS in hOD-1 stimulating IL-6 levels about 50-fold. HEMA inhibited the LPS- and LTA-induced IL-6 release, and this effect was enhanced by BSO but counteracted by NAC in both cell types. IL-6 release was independent of cell survival rates.

Conclusions: The protective immune response in odontoblasts and pulp fibroblasts is impaired by monomers such as HEMA through the disturbance of the redox homeostasis.

Keywords: Cytokine; HEMA; LPS; LTA; Odontoblasts; Oxidative stress; Pulp cells; Resin monomer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Dental Pulp / metabolism
  • Humans
  • Interleukin-6
  • Lipopolysaccharides* / pharmacology
  • Methacrylates
  • Tumor Necrosis Factor-alpha* / metabolism

Substances

  • Interleukin-6
  • Lipopolysaccharides
  • Methacrylates
  • Tumor Necrosis Factor-alpha
  • hydroxyethyl methacrylate